FETAL METABOLIC PROGRAMMING IN THE ETIOLOGY OF POLYCYSTIC OVARIAN SYNDROME

Authors

  • Mariana Prandi Leite da Silva
  • Rodrigo Vargas

DOI:

https://doi.org/10.56083/RCV3N8-028

Keywords:

Metabolic Syndrome, Fetal Development, Hyperandrogenis

Abstract

Polycystic ovary syndrome (PCOS) is an endocrine dysfunction, which can be characterized by hyperandrogenism and chronic anovulation. The main signs of PCOS are amenorrhea and polycystic forms in the ovaries, being the most common disorder in women in menacme and very commonly associated with other metabolic syndromes. Studies suggest that one of the etiological factors of the syndrome is related to fetal metabolic programming, maternal, nutritional, genetic and environmental influences are determinant in the emergence of diseases, including PCOS. The objective of this work is to relate the fetal metabolic programming with the development of PCOS. The study methodology consists in a literature review, through research in PubMed and Scielo databases. It is concluded that factors such as placental pathologies and maternal metabolism, fetal hypoxia, intrauterine growth restriction, low birth weight, maternal hyperandrogenism state and pathologies that corroborate this, hyperinsulinemia, and insulin resistance (IR), in addition to maternal exposure to plastic components, such as bisphenol A, are factors associated with the etiology of PCOS. Thus, during pregnancy, care must be taken to minimize the chances of future adolescents developing the syndrome and the various comorbidities that are associated with it.

References

- de Melo AS, Dias SV, Cavalli R de C, Cardoso VC, Bettiol H, Barbieri MA, et al. Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause. REPRODUCTION. 2015 Jul;150(1):R11–24. DOI: https://doi.org/10.1530/REP-14-0499

- Rosa-e-Silva AC. Conceito, epidemiologia e fisiopatologia aplicada à prática clínica: Síndrome dos ovários policísticos. São Paulo. Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO), 2019; 47(9), cap. 1, 1-15.

- Ribeiro VB, Kogure GS, Silva RC, Souza HCD, Ferriani RA, Reis RM dos. Increased Sympathetic Cardiac Autonomic Modulation after Two Consecutive Tilt Tests in Women with Polycystic Ovary Syndrome. Revista Brasileira de Ginecologia e Obstetrícia/RBGO Gynecology and Obstetrics. 2020 Feb;42(02):081–9. DOI: https://doi.org/10.1055/s-0040-1701467

- Moura HHG de, Costa DLM, Bagatin E, Sodré CT, Manela-Azulay M. Síndrome do ovário policístico: abordagem dermatológica. Anais Brasileiros de Dermatologia. 2011 Feb;86(1):111–9. DOI: https://doi.org/10.1590/S0365-05962011000100015

- Soares E, Dalva M, Elisabeth M. Hormonal Biomarkers for Evaluating the Impact of Fetal Growth Restriction on the Development of Chronic Adult Disease. 2019 Apr 1;41(04):256–63. DOI: https://doi.org/10.1055/s-0039-1683904

- Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, et al. Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. International Journal of Molecular Sciences. 2022 Jan 6;23(2):583. DOI: https://doi.org/10.3390/ijms23020583

- Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM, Schaffer JI, Corton M. Williams Gynecology. 4 Ed. Mcgraw Hill, 2020.

- Lana MP, Demayo S, Giannone L, Nolting M, D’isa E, Servetti V, et al. Metabolic compromise in women with PCOS: earlier than expected. Revista da Associação Médica Brasileira. 2020 Sep;66(9):1225–8. DOI: https://doi.org/10.1590/1806-9282.66.9.1225

- Rezende M, Faria N, Dias T, Oliveira W, Rocha A, Cândido A, et al. Association between Lipid Accumulation Product and Hirsutism in Patients with Polycystic Ovary Syndrome. Revista Brasileira de Ginecologia e Obstetrícia/RBGO Gynecology and Obstetrics. 2016 Feb 24;38(02):071–6. DOI: https://doi.org/10.1055/s-0036-1571423

- Wanderley M, Pereira L, Santos C, Cunha V, Neves M. Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics. 2018 Apr;40(04):188–95. DOI: https://doi.org/10.1055/s-0038-1642634

- Escobar-Morreale HF. Polycystic ovary syndrome: definition, etiology, diagnosis and treatment. Nature Reviews Endocrinology. 2018 Mar 23;14(5):270–84. DOI: https://doi.org/10.1038/nrendo.2018.24

- Guyton AC, Hall JE. Tratado de Fisiologia Médica. Editora Elsevier. 14ª ed, 2021.

- Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: What’s new? Advances in Clinical and Experimental Medicine. 2017 Apr 27;26(2):359–67. DOI: https://doi.org/10.17219/acem/59380

- Jiang J, Gao S, Zhang Y. Therapeutic effects of dimethyldiguanide combined with clomifene citrate in the treatment of polycystic ovary syndrome. 2019 Oct 10;65(9):1144–50. DOI: https://doi.org/10.1590/1806-9282.65.9.1144

- Luan Y, Zhang L, Peng Y, Li Y, Liu R, Yin C. Immune regulation in polycystic ovary syndrome. Clinica Chimica Acta. 2022 Jun;531:265–72. DOI: https://doi.org/10.1016/j.cca.2022.04.234

- Sik B, Ozan Ozolcay, Yılda Arzu Aba, Alper Sismanoglu, Savas S, Serkan Oral. Prevention of Premature Ovulation by Administration of Gonadotropin Releasing Hormone Antagonist the day After Ovulation Triggering in Diminished Ovarian Reserve Patients. 2022 Feb 9;44(3):245-250. DOI: https://doi.org/10.1055/s-0041-1736297

- Li Y, Chen C, Ma Y, Xiao J, Luo G, Li Y, et al. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sciences [Internet]. 2019 Jul 1;228:167–75. DOI: https://doi.org/10.1016/j.lfs.2019.04.046

- Osibogun O, Ogunmoroti O, Michos ED. Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention. Trends in Cardiovascular Medicine. 2020 Oct;30(7):399–404. DOI: https://doi.org/10.1016/j.tcm.2019.08.010

- Gislaine Satyko Kogure, Victor Barbosa Ribeiro, Gaona F, Rui Alberto Ferriani, Cristiana Libardi Miranda-Furtado, Maria R. Physical Performance Regarding Handgrip Strength in Women with Polycystic Ovary Syndrome. 2020 Dec 21;42(12):811–9. DOI: https://doi.org/10.1055/s-0040-1718953

- Porth CM, Matfin G. Fisiopatologia. 10ª ed. Guanabara Koogan, 2021.

- Yarak S, Bagatin E, Hassun KM, Parada MOAB, Talarico Filho S. Hiperandrogenismo e pele: síndrome do ovário policístico e resistência periférica à insulina. Anais Brasileiros de Dermatologia. 2005 Aug;80(4):395–410. DOI: https://doi.org/10.1590/S0365-05962005000400011

- Fu L, Qu F, Pan J, Wang T, Wang F. Polycystic ovary syndrome in adolescents with obesity. Revista da Associação Médica Brasileira. 2021 Mar;67(3):468–73. DOI: https://doi.org/10.1590/1806-9282.20200890

- Medeiros SF de, Barbosa BB, Medeiros MAS de, Yamamoto AKLW, Yamamoto MMW. Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome. Revista Brasileira de Ginecologia e Obstetrícia/RBGO Gynecology and Obstetrics. 2022 Feb;44(02):142–53. DOI: https://doi.org/10.1055/s-0041-1741030

- Lavor CBH, Viana Júnior AB, Medeiros F das C. Polycystic Ovary Syndrome and Metabolic Syndrome: Clinical and Laboratory Findings and Non-Alcoholic Fatty Liver Disease Assessed by Elastography. Revista Brasileira de Ginecologia e Obstetrícia/RBGO Gynecology and Obstetrics. 2022 Mar;44(03):287–94. DOI: https://doi.org/10.1055/s-0041-1741032

- Park SY, Gautier JF, Chon S. Assessment of Insulin Secretion and Insulin Resistance in Human. Diabetes & Metabolism Journal. 2021 Sep 30;45(5):641–54. DOI: https://doi.org/10.4093/dmj.2021.0220

- Souza CT. Envolvimento da inflamação subclínica e do estresse oxidativo na resistência à insulina associada a obesidade. HU Revista. 2019 Apr 4;44(2):211–20. DOI: https://doi.org/10.34019/1982-8047.2018.v44.16950

- Ferrari F, Bock PM, Motta MT, Helal L. Biochemical and Molecular Mechanisms of Glucose Uptake Stimulated by Physical Exercise in Insulin Resistance State: Role of Inflammation. Arquivos Brasileiros de Cardiologia. 2019;113(6):1139-1148. DOI: https://doi.org/10.5935/abc.20190224

- Saltiel AR. Insulin signaling in health and disease. The Journal of Clinical Investigation. 2021 Jan 4;131(1). DOI: https://doi.org/10.1172/JCI142241

– Ibáñez L, Oberfield Sharon E, Witchel S, Auchus Richard J, Chang R Jeffrey, Codner E, et al. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Hormone Research in Paediatrics. 2017;88(6):371–95. DOI: https://doi.org/10.1159/000479371

- Czech MP. Mechanisms of insulin resistance related to white, beige, and brown adipocytes. Molecular Metabolism. 2020 Apr; 34:27–42. DOI: https://doi.org/10.1016/j.molmet.2019.12.014

– Santoleri D, Titchenell M. Resolving the Paradox of Hepatic Insulin Resistance. Cellular and Molecular Gastroenterology and Hepatology. 2019 Jan 1;7(2):447–56. DOI: https://doi.org/10.1016/j.jcmgh.2018.10.016

- Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sciences. 2019 Nov 1;236:116940. DOI: https://doi.org/10.1016/j.lfs.2019.116940

- Stepto NK, Moreno-Asso A, McIlvenna LC, Walters KA, Rodgers RJ. Molecular Mechanisms of Insulin Resistance in Polycystic Ovary Syndrome: Unraveling the Conundrum in Skeletal Muscle? The Journal of Clinical Endocrinology and Metabolism. 2019 Nov 1;104(11):5372–81. DOI: https://doi.org/10.1210/jc.2019-00167

- Yang Q, Vijayakumar A, Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism. Nature Reviews Molecular Cell Biology. 2018 Aug 13;19(10):654–72. DOI: https://doi.org/10.1038/s41580-018-0044-8

- Roldão CFC. Leite materno e programação metabólica: benefícios para a saúde a curto e a longo prazo. Tese (Mestrado Integrado em Medicina) - Instituto de Ciências Biomédicas Abel Salazar, da Universidade do Porto, Porto, Portugal, 2019;1-35.

- Andrade JG, Mathias MG. Maternal feeding in the gestational period and mother and child weight gain. Journal of the Health Sciences Institute. 2020;39(4):238-244.

- Ornellas F, Carapeto PV, Mandarim-de-Lacerda CA, Aguila MB. Obese fathers lead to an altered metabolism and obesity in their children in adulthood: review of experimental and human studies. Jornal de Pediatria. 2017 Nov;93(6):551–9. DOI: https://doi.org/10.1016/j.jped.2017.02.004

- Pereira LS. Avaliação do conteúdo global de metilação do DNA e expressão de sirtuínas no pulmão de ratos wistar. Tese (Mestrado em Ciências Biológicas) - Universidade Federal de Ouro Preto, Minas Gerais, Brasil, 2020;1-80.

- Sagvekar P, Dadachanji R, Patil K, Mukherjee, S. Pathomechanisms of polycystic ovary syndrome multidimensional approaches. Frontiers in Bioscience. 2018;10(3):384–422. DOI: https://doi.org/10.2741/e829

- Zugaib M, Francisco RPV. Zugaib obstetrícia, 4 ed, Manole, 2020.

- Kapaya H, Williams R, Elton G, Anumba D. Can Obstetric Risk Factors Predict Fetal Acidaemia at Birth? A Retrospective Case-Control Study. Journal of Pregnancy. 2018 Sep 2;2018:1–8. DOI: https://doi.org/10.1155/2018/2195965

- Sharma D, Shastri S, Sharma P. Intrauterine Growth Restriction: Antenatal and Postnatal Aspects. Clinical Medicine Insights: Pediatrics. 2016 Jan; 10:67-83.CMPed.S40070. DOI: https://doi.org/10.4137/CMPed.S40070

- Figueiredo FO, Pires MLE, Lemes LNA. Distúrbios do metabolismo glicídico na síndrome da apneia obstrutiva do sono. Revista Hospital Universitário Pedro Ernesto. 2016 Apr 8;15(1). DOI: https://doi.org/10.12957/rhupe.2016.22376

- Reynolds RM. Glucocorticoid excess and the developmental origins of disease: Two decades of testing the hypothesis – 2012 Curt Richter Award Winner. Psychoneuroendocrinology. 2013 Jan;38(1):1–11. DOI: https://doi.org/10.1016/j.psyneuen.2012.08.012

- Zeng X, Xie Y, Liu Y, Long S, Mo Z. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clinica Chimica Acta. 2020 Mar; 502:214–21. DOI: https://doi.org/10.1016/j.cca.2019.11.003

- Calina D, Docea A, Golokhvast K, Sifakis S, Tsatsakis A, Makrigiannakis A. Management of Endocrinopathies in Pregnancy: A Review of Current Evidence. International Journal of Environmental Research and Public Health. 2019 Mar 4;16(5):781. DOI: https://doi.org/10.3390/ijerph16050781

- Kabir ER, Rahman MS, Rahman I. A review on endocrine disruptors and their possible impacts on human health. Environmental Toxicology and Pharmacology. 2015 Jul;40(1):241–58. DOI: https://doi.org/10.1016/j.etap.2015.06.009

- Yilmaz B, Terekeci H, Sandal S, Kelestimur F. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention. Reviews in Endocrine and Metabolic Disorders. 2019 Dec 3;21(1):127–47. DOI: https://doi.org/10.1007/s11154-019-09521-z

- Soave I, Tommaso Occhiali, Chiara Assorgi, Marci R, Caserta D. Environmental toxin exposure in polycystic ovary syndrome women and possible ovarian neoplastic repercussion. 2020 Feb 27;36(4):693–703. DOI: https://doi.org/10.1080/03007995.2020.1729108

Downloads

Published

2023-08-04

How to Cite

da Silva, M. P. L., & Vargas, R. (2023). FETAL METABOLIC PROGRAMMING IN THE ETIOLOGY OF POLYCYSTIC OVARIAN SYNDROME. Revista Contemporânea, 3(8), 10436–10450. https://doi.org/10.56083/RCV3N8-028

Issue

Section

Articles